3 Things You Should Know About Future Directions for BsAbs and ADCs in NSCLC
The latest advancements in bispecific antibodies and antibody-drug conjugates continue to improve the personalized treatment of advanced non-small cell lung cancer.
3 Things You Should Know About ADCs in Early-Stage TNBC and Considerations for Implementation
Explore the latest advancements in antibody-drug conjugates for treating metastatic triple-negative breast cancer and their unique safety profiles.
Why Survivorship Matters: Creating Space in Multidisciplinary Cancer Care
Oncology care requires psychosocial support, nutrition, and survivorship, which can result in improved patient outcomes and quality of life.
Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers
The Role of Artificial Intelligence in Palliative Oncology: Zeroing in on Hematologic Malignancies
AI revolutionizes palliative oncology by enhancing prognostication, symptom management, and personalized care for patients with hematologic malignancies.
A Decline in the US Oncology Workforce: What Will the Next Decade Bring?
Rising cancer diagnoses in the US highlight urgent needs for improved oncology education, workforce distribution, and care infrastructure, especially in rural areas.
